Continental Seeds and Chemicals Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: April 13, 2025, 10:00 pm

Market Cap	31.4 Cr.
Current Price	28.5
High / Low	70.2/20.9
Stock P/E
Book Value	21.8
Dividend Yield	0.00 %
ROCE	10.0 %
ROE	18.0 %
Face Value	10.0
PEG Ratio	0.00

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for Continental Seeds and Chemicals Ltd

Competitors of Continental Seeds and Chemicals Ltd

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
Genomic Valley Biotech Ltd	19.0 Cr.	62.1	108/28.4	47.4	12.5	0.00 %	0.57 %	0.57 %	10.0
Genesis IBRC India Ltd	23.8 Cr.	18.3	18.3/13.7		6.58	0.00 %	54.8 %	54.8 %	10.0
Shreeoswal Seeds & Chemicals Ltd	140 Cr.	15.3	40.8/11.6		4.13	0.00 %	0.62 %	9.84 %	2.00
Nath Bio-Genes (India) Ltd	307 Cr.	162	264/138	7.37	339	1.23 %	6.85 %	6.23 %	10.0
Continental Seeds and Chemicals Ltd	31.4 Cr.	28.5	70.2/20.9		21.8	0.00 %	10.0 %	18.0 %	10.0
Industry Average	223.50 Cr	57.24		27.39	76.80	0.25%	14.57%	17.89%	8.40

All Competitor Stocks of Continental Seeds and Chemicals Ltd

Quarterly Result

Metric	Sep 2019	Mar 2020	Sep 2020	Mar 2021	Sep 2021	Sep 2022	Sep 2023	Mar 2024	Sep 2024
Sales	25	63	38	57	38	57	39	58	44
Expenses	25	62	38	56	38	56	38	60	42
Operating Profit	1	1	1	1	1	1	2	-2	1
OPM %	2%	1%	2%	1%	2%	1%	4%	-3%	3%
Other Income	0	0	0	0	0	0	0	4	2
Interest	0	0	0	0	0	0	0	0	0
Depreciation	0	0	0	0	0	0	1	2	1
Profit before tax	0	1	0	0	0	0	0	1	2
Tax %	90%	3%	31%	0%	31%	0%	-8%	21%	23%
Net Profit	0	1	0	0	0	0	0	1	1
EPS in Rs	0.01	0.63	0.23	0.14	0.23	0.14	0.12	0.54	1.06

Last Updated: March 3, 2025, 4:56 pm

Below is a detailed analysis of the quarterly data for Continental Seeds and Chemicals Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:

For Sales, as of Sep 2024, the value is 44.00 Cr.. The value appears to be declining and may need further review. It has decreased from 58.00 Cr. (Mar 2024) to 44.00 Cr., marking a decrease of 14.00 Cr..
For Expenses, as of Sep 2024, the value is 42.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 60.00 Cr. (Mar 2024) to 42.00 Cr., marking a decrease of 18.00 Cr..
For Operating Profit, as of Sep 2024, the value is 1.00 Cr.. The value appears strong and on an upward trend. It has increased from -2.00 Cr. (Mar 2024) to 1.00 Cr., marking an increase of 3.00 Cr..
For OPM %, as of Sep 2024, the value is 3.00%. The value appears strong and on an upward trend. It has increased from -3.00% (Mar 2024) to 3.00%, marking an increase of 6.00%.
For Other Income, as of Sep 2024, the value is 2.00 Cr.. The value appears to be declining and may need further review. It has decreased from 4.00 Cr. (Mar 2024) to 2.00 Cr., marking a decrease of 2.00 Cr..
For Interest, as of Sep 2024, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
For Depreciation, as of Sep 2024, the value is 1.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 2.00 Cr. (Mar 2024) to 1.00 Cr., marking a decrease of 1.00 Cr..
For Profit before tax, as of Sep 2024, the value is 2.00 Cr.. The value appears strong and on an upward trend. It has increased from 1.00 Cr. (Mar 2024) to 2.00 Cr., marking an increase of 1.00 Cr..
For Tax %, as of Sep 2024, the value is 23.00%. The value appears to be increasing, which may not be favorable. It has increased from 21.00% (Mar 2024) to 23.00%, marking an increase of 2.00%.
For Net Profit, as of Sep 2024, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 1.00 Cr..
For EPS in Rs, as of Sep 2024, the value is 1.06. The value appears strong and on an upward trend. It has increased from 0.54 (Mar 2024) to 1.06, marking an increase of 0.52.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: March 7, 2025, 8:53 pm

Metric	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM
Sales	1	55	58	58	58	82	82	88	95	98	75	98	102
Expenses	1	54	57	57	57	80	80	86	94	96	72	98	102
Operating Profit	-0	0	1	1	1	2	2	1	1	2	4	-0	-0
OPM %	-21%	0%	2%	1%	3%	2%	2%	2%	2%	2%	5%	-0%	-0%
Other Income	0	0	0	0	0	0	0	0	0	0	0	4	6
Interest	0	0	0	1	1	1	1	0	1	0	1	1	1
Depreciation	0	0	0	0	0	0	0	0	1	1	4	3	3
Profit before tax	0	0	0	0	1	1	1	1	0	0	0	1	2
Tax %	17%	28%	32%	26%	34%	32%	45%	26%	22%	47%	50%	16%
Net Profit	0	0	0	0	0	1	0	1	0	0	0	1	2
EPS in Rs	0.71	1.05	1.29	0.76	2.24	0.72	0.46	0.65	0.37	0.19	0.02	0.67	1.60
Dividend Payout %	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2018-2019	2020-2021
YoY Net Profit Growth (%)	-100.00%	-100.00%
Change in YoY Net Profit Growth (%)	0.00%	0.00%

Continental Seeds and Chemicals Ltd has shown a consistent positive trend in YoY Net Profit Growth (%) in the last 2 years from 2018-2019 to 2020-2021.

Growth

Compounded Sales Growth
10 Years:	6%
5 Years:	4%
3 Years:	1%
TTM:	30%

Compounded Profit Growth
10 Years:	%
5 Years:	%
3 Years:	%
TTM:	-582%

Stock Price CAGR
10 Years:	%
5 Years:	15%
3 Years:	42%
1 Year:	24%

Return on Equity
10 Years:	1%
5 Years:	-2%
3 Years:	-6%
Last Year:	-18%

Last Updated: Unknown

Balance Sheet

Last Updated: November 15, 2024, 1:30 am

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Sep 2024
Equity Capital	1	1	1	1	1	6	6	10	10	10	10	10	10
Reserves	3	4	4	4	4	5	5	2	2	2	2	3	14
Borrowings	0	0	3	4	5	4	4	5	8	6	6	5	1
Other Liabilities	1	1	2	3	2	22	14	6	14	14	12	8	7
Total Liabilities	5	5	9	12	13	36	29	22	33	32	31	27	33
Fixed Assets	1	1	0	0	2	1	2	3	5	21	18	16	15
CWIP	0	0	0	0	0	0	1	5	12	0	0	0	1
Investments	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Assets	4	5	9	12	11	35	26	14	17	11	13	10	17
Total Assets	5	5	9	12	13	36	29	22	33	32	31	27	33

Below is a detailed analysis of the balance sheet data for Continental Seeds and Chemicals Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:

For Equity Capital, as of Sep 2024, the value is ₹10.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 10.00 Cr..
For Reserves, as of Sep 2024, the value is ₹14.00 Cr.. The value appears strong and on an upward trend. It has increased from 3.00 Cr. (Mar 2024) to ₹14.00 Cr., marking an increase of 11.00 Cr..
For Borrowings, as of Sep 2024, the value is ₹1.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 5.00 Cr. (Mar 2024) to ₹1.00 Cr., marking a decrease of 4.00 Cr..
For Other Liabilities, as of Sep 2024, the value is ₹7.00 Cr.. The value appears to be improving (decreasing). It has decreased from 8.00 Cr. (Mar 2024) to ₹7.00 Cr., marking a decrease of 1.00 Cr..
For Total Liabilities, as of Sep 2024, the value is ₹33.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 27.00 Cr. (Mar 2024) to ₹33.00 Cr., marking an increase of 6.00 Cr..
For Fixed Assets, as of Sep 2024, the value is ₹15.00 Cr.. The value appears to be declining and may need further review. It has decreased from 16.00 Cr. (Mar 2024) to ₹15.00 Cr., marking a decrease of 1.00 Cr..
For CWIP, as of Sep 2024, the value is ₹1.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Mar 2024) to ₹1.00 Cr., marking an increase of 1.00 Cr..
For Investments, as of Sep 2024, the value is ₹0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
For Other Assets, as of Sep 2024, the value is ₹17.00 Cr.. The value appears strong and on an upward trend. It has increased from 10.00 Cr. (Mar 2024) to ₹17.00 Cr., marking an increase of 7.00 Cr..
For Total Assets, as of Sep 2024, the value is ₹33.00 Cr.. The value appears strong and on an upward trend. It has increased from 27.00 Cr. (Mar 2024) to ₹33.00 Cr., marking an increase of 6.00 Cr..

Notably, the Reserves (14.00 Cr.) exceed the Borrowings (1.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

Month	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Cash from Operating Activity +	2	1	-2	5	7	8	6	3
Cash from Investing Activity +	-1	0	-2	-4	-8	-7	-1	-1
Cash from Financing Activity +	-0	3	-1	-1	1	-0	-0	-2
Net Cash Flow	-0	4	-4	0	-0	0	5	0

Free Cash Flow

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Free Cash Flow	0.00	0.00	-2.00	-3.00	-4.00	-2.00	-2.00	-4.00	-7.00	-4.00	-2.00	-5.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Debtor Days	264.31	4.95	9.55	42.68	37.89	111.80	57.26	13.28	33.87	9.14	17.81	12.74
Inventory Days	256.85	1.97	32.35	19.39	21.47	16.45	16.50	21.19	21.95	23.75	16.75	13.09
Days Payable	6.76	0.07	5.34	13.72	0.13	95.65	59.47	12.83	33.71	73.24	33.22	9.56
Cash Conversion Cycle	514.40	6.85	36.57	48.35	59.23	32.60	14.29	21.63	22.11	-40.36	1.34	16.27
Working Capital Days	1,787.24	13.31	37.52	51.92	53.50	34.70	24.27	22.40	-0.96	-24.02	6.15	7.10
ROCE %		6.25%	11.98%	8.94%	13.76%	13.64%	10.95%	7.77%	6.54%	4.26%	3.30%	-10.00%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Sep 2021	Dec 2021	Mar 2022	Sep 2022	Mar 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Feb 2025
Promoters	72.27%	72.27%	72.27%	72.27%	72.27%	72.27%	72.27%	72.27%	72.27%	65.71%	65.71%	56.91%
FIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	13.38%
Public	27.72%	27.73%	27.73%	27.73%	27.74%	27.73%	27.73%	27.73%	27.73%	34.29%	34.29%	29.70%
No. of Shareholders	312	313	306	306	308	324	313	306	301	341	330	332

Shareholding Pattern Chart

No. of Shareholders

This stock is not held by any mutual fund

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
FaceValue	10.00	10.00	10.00	10.00	10.00
Basic EPS (Rs.)	0.67	0.02	0.19	0.37	1.00
Diluted EPS (Rs.)	0.67	0.02	0.19	0.37	1.00
Cash EPS (Rs.)	3.64	3.54	1.44	0.98	1.09
Book Value[Excl.RevalReserv]/Share (Rs.)	12.69	12.30	12.23	12.03	11.68
Book Value[Incl.RevalReserv]/Share (Rs.)	12.69	12.30	12.23	12.03	11.68
Revenue From Operations / Share (Rs.)	97.65	75.39	97.86	95.37	87.89
PBDIT / Share (Rs.)	1.13	4.12	2.04	1.69	1.63
PBIT / Share (Rs.)	-1.84	0.60	0.79	1.08	1.19
PBT / Share (Rs.)	0.79	0.02	0.37	0.48	0.86
Net Profit / Share (Rs.)	0.66	0.01	0.18	0.37	0.64
PBDIT Margin (%)	1.16	5.46	2.08	1.77	1.85
PBIT Margin (%)	-1.88	0.79	0.81	1.12	1.35
PBT Margin (%)	0.81	0.02	0.38	0.51	0.97
Net Profit Margin (%)	0.68	0.02	0.19	0.39	0.73
Return on Networth / Equity (%)	5.24	0.13	1.52	3.11	5.54
Return on Capital Employeed (%)	-10.48	3.14	5.40	6.85	8.91
Return On Assets (%)	2.51	0.05	0.59	1.12	2.90
Long Term Debt / Equity (X)	0.13	0.22	0.19	0.29	0.13
Total Debt / Equity (X)	0.36	0.44	0.41	0.55	0.39
Asset Turnover Ratio (%)	3.41	2.42	3.01	3.42	3.44
Current Ratio (X)	0.88	0.87	0.50	0.84	1.30
Quick Ratio (X)	0.53	0.62	0.29	0.65	0.75
Inventory Turnover Ratio (X)	2.63	0.99	9.28	7.42	0.00
Interest Coverage Ratio (X)	2.12	7.75	5.32	3.12	3.83
Interest Coverage Ratio (Post Tax) (X)	-3.69	1.12	1.58	1.78	2.30
Enterprise Value (Cr.)	27.54	18.24	14.60	12.26	26.91
EV / Net Operating Revenue (X)	0.28	0.24	0.14	0.12	0.30
EV / EBITDA (X)	24.31	4.43	7.14	7.25	16.50
MarketCap / Net Operating Revenue (X)	0.23	0.16	0.10	0.06	0.25
Price / BV (X)	1.81	1.04	0.84	0.49	1.94
Price / Net Operating Revenue (X)	0.23	0.16	0.10	0.06	0.25
EarningsYield	0.02	0.00	0.01	0.06	0.02

After reviewing the key financial ratios for Continental Seeds and Chemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:

For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
For Basic EPS (Rs.), as of Mar 24, the value is 0.67. This value is below the healthy minimum of 5. It has increased from 0.02 (Mar 23) to 0.67, marking an increase of 0.65.
For Diluted EPS (Rs.), as of Mar 24, the value is 0.67. This value is below the healthy minimum of 5. It has increased from 0.02 (Mar 23) to 0.67, marking an increase of 0.65.
For Cash EPS (Rs.), as of Mar 24, the value is 3.64. This value is within the healthy range. It has increased from 3.54 (Mar 23) to 3.64, marking an increase of 0.10.
For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 12.69. It has increased from 12.30 (Mar 23) to 12.69, marking an increase of 0.39.
For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 12.69. It has increased from 12.30 (Mar 23) to 12.69, marking an increase of 0.39.
For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 97.65. It has increased from 75.39 (Mar 23) to 97.65, marking an increase of 22.26.
For PBDIT / Share (Rs.), as of Mar 24, the value is 1.13. This value is below the healthy minimum of 2. It has decreased from 4.12 (Mar 23) to 1.13, marking a decrease of 2.99.
For PBIT / Share (Rs.), as of Mar 24, the value is -1.84. This value is below the healthy minimum of 0. It has decreased from 0.60 (Mar 23) to -1.84, marking a decrease of 2.44.
For PBT / Share (Rs.), as of Mar 24, the value is 0.79. This value is within the healthy range. It has increased from 0.02 (Mar 23) to 0.79, marking an increase of 0.77.
For Net Profit / Share (Rs.), as of Mar 24, the value is 0.66. This value is below the healthy minimum of 2. It has increased from 0.01 (Mar 23) to 0.66, marking an increase of 0.65.
For PBDIT Margin (%), as of Mar 24, the value is 1.16. This value is below the healthy minimum of 10. It has decreased from 5.46 (Mar 23) to 1.16, marking a decrease of 4.30.
For PBIT Margin (%), as of Mar 24, the value is -1.88. This value is below the healthy minimum of 10. It has decreased from 0.79 (Mar 23) to -1.88, marking a decrease of 2.67.
For PBT Margin (%), as of Mar 24, the value is 0.81. This value is below the healthy minimum of 10. It has increased from 0.02 (Mar 23) to 0.81, marking an increase of 0.79.
For Net Profit Margin (%), as of Mar 24, the value is 0.68. This value is below the healthy minimum of 5. It has increased from 0.02 (Mar 23) to 0.68, marking an increase of 0.66.
For Return on Networth / Equity (%), as of Mar 24, the value is 5.24. This value is below the healthy minimum of 15. It has increased from 0.13 (Mar 23) to 5.24, marking an increase of 5.11.
For Return on Capital Employeed (%), as of Mar 24, the value is -10.48. This value is below the healthy minimum of 10. It has decreased from 3.14 (Mar 23) to -10.48, marking a decrease of 13.62.
For Return On Assets (%), as of Mar 24, the value is 2.51. This value is below the healthy minimum of 5. It has increased from 0.05 (Mar 23) to 2.51, marking an increase of 2.46.
For Long Term Debt / Equity (X), as of Mar 24, the value is 0.13. This value is below the healthy minimum of 0.2. It has decreased from 0.22 (Mar 23) to 0.13, marking a decrease of 0.09.
For Total Debt / Equity (X), as of Mar 24, the value is 0.36. This value is within the healthy range. It has decreased from 0.44 (Mar 23) to 0.36, marking a decrease of 0.08.
For Asset Turnover Ratio (%), as of Mar 24, the value is 3.41. It has increased from 2.42 (Mar 23) to 3.41, marking an increase of 0.99.
For Current Ratio (X), as of Mar 24, the value is 0.88. This value is below the healthy minimum of 1.5. It has increased from 0.87 (Mar 23) to 0.88, marking an increase of 0.01.
For Quick Ratio (X), as of Mar 24, the value is 0.53. This value is below the healthy minimum of 1. It has decreased from 0.62 (Mar 23) to 0.53, marking a decrease of 0.09.
For Inventory Turnover Ratio (X), as of Mar 24, the value is 2.63. This value is below the healthy minimum of 4. It has increased from 0.99 (Mar 23) to 2.63, marking an increase of 1.64.
For Interest Coverage Ratio (X), as of Mar 24, the value is 2.12. This value is below the healthy minimum of 3. It has decreased from 7.75 (Mar 23) to 2.12, marking a decrease of 5.63.
For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is -3.69. This value is below the healthy minimum of 3. It has decreased from 1.12 (Mar 23) to -3.69, marking a decrease of 4.81.
For Enterprise Value (Cr.), as of Mar 24, the value is 27.54. It has increased from 18.24 (Mar 23) to 27.54, marking an increase of 9.30.
For EV / Net Operating Revenue (X), as of Mar 24, the value is 0.28. This value is below the healthy minimum of 1. It has increased from 0.24 (Mar 23) to 0.28, marking an increase of 0.04.
For EV / EBITDA (X), as of Mar 24, the value is 24.31. This value exceeds the healthy maximum of 15. It has increased from 4.43 (Mar 23) to 24.31, marking an increase of 19.88.
For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 0.23. This value is below the healthy minimum of 1. It has increased from 0.16 (Mar 23) to 0.23, marking an increase of 0.07.
For Price / BV (X), as of Mar 24, the value is 1.81. This value is within the healthy range. It has increased from 1.04 (Mar 23) to 1.81, marking an increase of 0.77.
For Price / Net Operating Revenue (X), as of Mar 24, the value is 0.23. This value is below the healthy minimum of 1. It has increased from 0.16 (Mar 23) to 0.23, marking an increase of 0.07.
For EarningsYield, as of Mar 24, the value is 0.02. This value is below the healthy minimum of 5. It has increased from 0.00 (Mar 23) to 0.02, marking an increase of 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Continental Seeds and Chemicals Ltd as of April 17, 2025 is: 48.03

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of April 17, 2025, Continental Seeds and Chemicals Ltd is Undervalued by 68.53% compared to the current share price 28.50

Default values used*: Default value of 15 for Stock P/E is used

Intrinsic Value of Continental Seeds and Chemicals Ltd as of April 17, 2025 is: 64.37

Calculation basis:

Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of April 17, 2025, Continental Seeds and Chemicals Ltd is Undervalued by 125.86% compared to the current share price 28.50

Default values used*: Default value of 15 for Stock P/E is used

Last 5 Year EPS CAGR: 34.02%

*Investments are subject to market risks

Strength and Weakness

Strength	Weakness
The stock has a low average Working Capital Days of 18.91, which is a positive sign. The company has higher reserves (4.15 cr) compared to borrowings (3.92 cr), indicating strong financial stability. The company has shown consistent growth in sales (73.08 cr) and profit (0.54 cr) over the years.	The stock has a low average ROCE of 6.45%, which may not be favorable. The stock has a high average Cash Conversion Cycle of 61.11, which may not be favorable.

Stock Analysis

Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Continental Seeds and Chemicals Ltd:
1. Net Profit Margin: 0.68%
  - Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
2. ROCE: -10.48% (Industry Average ROCE: 14.57%)
  - ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
3. ROE%: 5.24% (Industry Average ROE: 17.89%)
  - ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
4. Interest Coverage Ratio (Post Tax): -3.69
  - Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
5. Quick Ratio: 0.53
  - Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
6. Stock P/E: 0 (Industry average Stock P/E: 27.39)
  - Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
7. Total Debt / Equity: 0.36
  - Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
Stock Rating:

About the Company - Qualitative Analysis

Continental Seeds and Chemicals Ltd. is a Public Limited Listed company incorporated on 22/06/1983 and has its registered office in the State of Delhi, India. Company's Corporate Identification Number(CIN) is L01111DL1983PLC015969 and registration number is 015969. Currently Company is involved in the business activities of Activities of commission agents dealing in wholesale trade inwood, paper, skin, leather and fur, fuel, petroleum products, chemicals, perfumery and cosmetics, glass, minerals, ores and metals. Company's Total Operating Revenue is Rs. 97.68 Cr. and Equity Capital is Rs. 10.00 Cr. for the Year ended 31/03/2024.

INDUSTRY	ADDRESS	CONTACT
Seeds/Tissue Culture/Bio Technology	DTJ-114, DLF Tower B, Jasola, New Delhi Delhi 110025	info@continentalseeds.co.in http://www.continentalseeds.co.in

Management
Name	Position Held
Mr. Pravin Rastogi	Chairman & Managing Director
Mrs. Nidhi Gupta	Executive & Women Director
Mr. Sachin Rastogi	Non Executive Director
Mr. Prashant Rastogi	Independent Director
Mr. Gopal Krishan Sharma	Independent Director
Mr. Vivek Kumar Mathur	Independent Director

FAQ

What is the intrinsic value of Continental Seeds and Chemicals Ltd?

Continental Seeds and Chemicals Ltd's intrinsic value (as of 14 April 2025) is ₹48.03 — 68.53% higher the current market price of 28.50, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's 31.4 Cr. market cap, FY2025-2026 high/low of ₹70.2/20.9, reserves of 14 Cr, and liabilities of 33 Cr.

What is the Market Cap of Continental Seeds and Chemicals Ltd?

The Market Cap of Continental Seeds and Chemicals Ltd is 31.4 Cr..

What is the current Stock Price of Continental Seeds and Chemicals Ltd as on 14 April 2025?

The current stock price of Continental Seeds and Chemicals Ltd as on 14 April 2025 is 28.5.

What is the High / Low of Continental Seeds and Chemicals Ltd stocks in FY 2025-2026?

In FY 2025-2026, the High / Low of Continental Seeds and Chemicals Ltd stocks is ₹70.2/20.9.

What is the Stock P/E of Continental Seeds and Chemicals Ltd?

The Stock P/E of Continental Seeds and Chemicals Ltd is .

What is the Book Value of Continental Seeds and Chemicals Ltd?

The Book Value of Continental Seeds and Chemicals Ltd is 21.8.

What is the Dividend Yield of Continental Seeds and Chemicals Ltd?

The Dividend Yield of Continental Seeds and Chemicals Ltd is 0.00 %.

What is the ROCE of Continental Seeds and Chemicals Ltd?

The ROCE of Continental Seeds and Chemicals Ltd is 10.0 %.

What is the ROE of Continental Seeds and Chemicals Ltd?

The ROE of Continental Seeds and Chemicals Ltd is 18.0 %.

What is the Face Value of Continental Seeds and Chemicals Ltd?

The Face Value of Continental Seeds and Chemicals Ltd is 10.0.